Osmotica Pharmaceuticals Plc. (OSMT) NASDAQ
$1.13 - (-)
Market Cap: $94.12M
As of 01/14/22 12:00 AM EST. Market closed.
Osmotica Pharmaceuticals Plc. (OSMT)
NASDAQ
$1.13
- (-)
Market Cap: $94.12M
As of 01/14/22 12:00 AM EST. Market closed.
Add to Portfolio
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
302
CEO Compensation (Base)
$633,262
URL
Address
400 Crossing Blvd, New Jersey, Bridgewater, 08807-2863.
PRICE CHART FOR OSMOTICA PHARMACEUTICALS PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.13
Previous Close
$1.13
Days Range
$1.09 - $1.14
52 week range
$0.98 - $4.95
Volume
0
Avg. Volume (30 days)
865,341
Market Cap
$94.12M
Dividend Yield
-
P/E
-
Shares Outstanding
83,289,831
Open
$1.13
Previous Close
$1.13
Days Range
$1.09 - $1.14
52 week range
$0.98 - $4.95
Volume
0
Avg. Volume (30 days)
865,341
Market Cap
$94.12M
Dividend Yield
-
P/E
-
Shares Outstanding
83,289,831
FINANCIAL STATEMENTS FOR OSMOTICA PHARMACEUTICALS PLC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR OSMOTICA PHARMACEUTICALS PLC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Harsaul Foundation | 10% Owner | Oct 20, 2023 | Sale | $0.03 | 4,758,899 | 148,478 | 4,941,101 | Oct 23, 2023, 04:23 PM |
| Harsaul Foundation | 10% Owner | Oct 19, 2023 | Sale | $0.05 | 9,363,760 | 431,669 | 9,700,000 | Oct 23, 2023, 04:23 PM |
| Altchem Ltd | 10% Owner | Oct 20, 2023 | Sale | $0.03 | 4,758,899 | 148,478 | 4,941,101 | Oct 23, 2023, 01:06 PM |
| Altchem Ltd | 10% Owner | Oct 19, 2023 | Sale | $0.05 | 9,363,760 | 431,669 | 9,700,000 | Oct 23, 2023, 01:06 PM |
| Harsaul Foundation | 10% Owner | Oct 18, 2023 | Sale | $0.06 | 3,421,537 | 221,031 | 19,063,760 | Oct 20, 2023, 03:59 PM |
| Altchem Ltd | 10% Owner | Oct 18, 2023 | Sale | $0.06 | 3,421,537 | 221,031 | 19,063,760 | Oct 20, 2023, 01:36 PM |
| Lask Alisa | Director | Aug 10, 2023 | Option Exercise | $0.49 | 12,000 | 5,880 | 112,557 | Aug 14, 2023, 05:35 PM |
| Schaub James | EVP and COO | May 18, 2023 | Option Exercise | $0.87 | 5,577 | 4,852 | 524,835 | May 22, 2023, 09:21 PM |
| Klein Christopher | General Counsel & Secretary | May 18, 2023 | Option Exercise | $0.87 | 5,447 | 4,739 | 180,573 | May 22, 2023, 09:18 PM |
| Klein Christopher | General Counsel & Secretary | Jan 24, 2023 | Option Exercise | $1.26 | 9,608 | 12,106 | 186,020 | Jan 26, 2023, 05:16 PM |
| Schaub James | EVP and COO | Jan 24, 2023 | Option Exercise | $1.26 | 9,608 | 12,106 | 530,412 | Jan 26, 2023, 05:15 PM |
| Schaub James | EVP and COO | Aug 08, 2022 | Buy | $1.55 | 150,000 | 232,500 | 540,020 | Aug 09, 2022, 05:23 PM |
| MARKISON BRIAN A | Chief Executive Officer | Aug 08, 2022 | Buy | $1.55 | 850,000 | 1,317,500 | 2,976,020 | Aug 09, 2022, 05:22 PM |
| Burgstahler David F | Director | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:21 PM |
| Venkataraman Sriram | Director | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:19 PM |
| Avista Healthcare Partners, L.P. | 10% Owner | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:18 PM |
| deVries Tina Marie | EVP, Research & Development | May 18, 2022 | Option Exercise | $1.40 | 5,447 | 7,626 | 136,141 | May 20, 2022, 04:28 PM |
| Klein Christopher | General Counsel & Secretary | May 18, 2022 | Option Exercise | $1.40 | 6,127 | 8,578 | 195,628 | May 20, 2022, 04:27 PM |
| Schaub James | EVP and COO | May 18, 2022 | Option Exercise | $1.40 | 6,273 | 8,782 | 390,020 | May 20, 2022, 04:25 PM |
| Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 141,473 | Jan 26, 2022, 04:31 PM |
| Klein Christopher | General Counsel & Secretary | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 201,755 | Jan 26, 2022, 04:31 PM |
| deVries Tina Marie | EVP, Research & Development | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 141,588 | Jan 26, 2022, 04:31 PM |
| Schaub James | EVP and COO | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 396,293 | Jan 26, 2022, 04:30 PM |
| Schaub James | EVP and COO | Dec 16, 2021 | Buy | $1.07 | 93,800 | 100,366 | 405,900 | Dec 20, 2021, 05:03 PM |
| COWAN GREGORY L | Director | Aug 27, 2021 | Option Exercise | $3.31 | 5,506 | 18,225 | 50,055 | Sep 03, 2021, 04:02 PM |
| WEISS FRED G | Director | Aug 27, 2021 | Option Exercise | $3.31 | 5,506 | 18,225 | 118,466 | Sep 03, 2021, 04:01 PM |
| COWAN GREGORY L | Director | Jun 18, 2021 | Option Exercise | $2.89 | 18,584 | 53,708 | 55,561 | Jun 22, 2021, 04:05 PM |
| Schaub James | EVP and COO | May 18, 2021 | Option Exercise | $3.12 | 6,621 | 20,658 | 312,100 | May 20, 2021, 04:07 PM |
| Klein Christopher | General Counsel & Secretary | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 211,362 | May 20, 2021, 04:06 PM |
| Einhorn Andrew J. | Chief Financial Officer | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 151,080 | May 20, 2021, 04:06 PM |
| deVries Tina Marie | EVP, Research & Development | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 151,195 | May 20, 2021, 04:05 PM |
| Schaub James | EVP and COO | Jan 24, 2021 | Option Exercise | $4.46 | 9,687 | 43,204 | 318,721 | Jan 26, 2021, 07:03 PM |
| Klein Christopher | General Counsel & Secretary | Jan 24, 2021 | Option Exercise | $4.46 | 9,605 | 42,838 | 217,829 | Jan 26, 2021, 07:03 PM |
| Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2021 | Option Exercise | $4.46 | 9,668 | 43,119 | 157,547 | Jan 26, 2021, 07:02 PM |
| deVries Tina Marie | EVP, Research & Development | Jan 24, 2021 | Option Exercise | $4.46 | 9,597 | 42,803 | 157,662 | Jan 26, 2021, 07:01 PM |
| WEISS FRED G | Director | Jan 24, 2021 | Option Exercise | $4.46 | 5,505 | 24,552 | 81,368 | Jan 26, 2021, 07:01 PM |
| COWAN GREGORY L | Director | Jan 24, 2021 | Option Exercise | $4.46 | 5,505 | 24,552 | 74,145 | Jan 26, 2021, 07:00 PM |
| COWAN GREGORY L | Director | May 21, 2020 | Option Exercise | $4.60 | 11,112 | 51,115 | 79,650 | May 22, 2020, 04:27 PM |
| WEISS FRED G | Director | May 21, 2020 | Option Exercise | $4.60 | 17,778 | 81,779 | 86,873 | May 22, 2020, 04:27 PM |
| COWAN GREGORY L | Director | Jan 28, 2020 | Option Exercise | $7.00 | 5,505 | 38,535 | 52,046 | Jan 30, 2020, 05:39 PM |
| Schaub James | EVP and COO | Jan 28, 2020 | Option Exercise | $7.00 | 9,197 | 64,379 | 255,155 | Jan 30, 2020, 05:39 PM |
| Klein Christopher | General Counsel & Secretary | Jan 28, 2020 | Option Exercise | $7.00 | 9,148 | 64,036 | 155,884 | Jan 30, 2020, 05:39 PM |
| Einhorn Andrew J. | Chief Financial Officer | Jan 28, 2020 | Option Exercise | $7.00 | 9,184 | 64,288 | 95,665 | Jan 30, 2020, 05:38 PM |
| WEISS FRED G | Director | Jan 28, 2020 | Option Exercise | $7.00 | 5,505 | 38,535 | 65,935 | Jan 30, 2020, 05:38 PM |
| deVries Tina Marie | EVP, Research & Development | Jan 28, 2020 | Option Exercise | $7.00 | 9,140 | 63,980 | 95,709 | Jan 30, 2020, 05:38 PM |
| Harsaul Foundation | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 22,485,297 | Jan 15, 2020, 04:54 PM |
| Altchem Ltd | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 22,485,297 | Jan 15, 2020, 04:39 PM |
| Venkataraman Sriram | Director | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:13 PM |
| Burgstahler David F | Director | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:11 PM |
| Avista Capital Partners III GP, L.P. | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:11 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Harsaul Foundation | 10% Owner | 10/20/2023 | 148,478 |
| Harsaul Foundation | 10% Owner | 10/19/2023 | 431,669 |
| Altchem Ltd | 10% Owner | 10/20/2023 | 148,478 |
| Altchem Ltd | 10% Owner | 10/19/2023 | 431,669 |
| Harsaul Foundation | 10% Owner | 10/18/2023 | 221,031 |
| Altchem Ltd | 10% Owner | 10/18/2023 | 221,031 |
| Lask Alisa | Director | 08/10/2023 | 5,880 |
| Schaub James | EVP and COO | 05/18/2023 | 4,852 |
| Klein Christopher | General Counsel & Secretary | 05/18/2023 | 4,739 |
| Klein Christopher | General Counsel & Secretary | 01/24/2023 | 12,106 |
| Schaub James | EVP and COO | 01/24/2023 | 12,106 |
| Schaub James | EVP and COO | 08/08/2022 | 232,500 |
| MARKISON BRIAN A | Chief Executive Officer | 08/08/2022 | 1,317,500 |
| Burgstahler David F | Director | 08/08/2022 | 12,400,000 |
| Venkataraman Sriram | Director | 08/08/2022 | 12,400,000 |
| Avista Healthcare Partners, L.P. | 10% Owner | 08/08/2022 | 12,400,000 |
| deVries Tina Marie | EVP, Research & Development | 05/18/2022 | 7,626 |
| Klein Christopher | General Counsel & Secretary | 05/18/2022 | 8,578 |
| Schaub James | EVP and COO | 05/18/2022 | 8,782 |
| Einhorn Andrew J. | Chief Financial Officer | 01/24/2022 | 10,856 |
| Klein Christopher | General Counsel & Secretary | 01/24/2022 | 10,856 |
| deVries Tina Marie | EVP, Research & Development | 01/24/2022 | 10,856 |
| Schaub James | EVP and COO | 01/24/2022 | 10,856 |
| Schaub James | EVP and COO | 12/16/2021 | 100,366 |
| COWAN GREGORY L | Director | 08/27/2021 | 18,225 |
| WEISS FRED G | Director | 08/27/2021 | 18,225 |
| COWAN GREGORY L | Director | 06/18/2021 | 53,708 |
| Schaub James | EVP and COO | 05/18/2021 | 20,658 |
| Klein Christopher | General Counsel & Secretary | 05/18/2021 | 20,177 |
| Einhorn Andrew J. | Chief Financial Officer | 05/18/2021 | 20,177 |
| deVries Tina Marie | EVP, Research & Development | 05/18/2021 | 20,177 |
| Schaub James | EVP and COO | 01/24/2021 | 43,204 |
| Klein Christopher | General Counsel & Secretary | 01/24/2021 | 42,838 |
| Einhorn Andrew J. | Chief Financial Officer | 01/24/2021 | 43,119 |
| deVries Tina Marie | EVP, Research & Development | 01/24/2021 | 42,803 |
| WEISS FRED G | Director | 01/24/2021 | 24,552 |
| COWAN GREGORY L | Director | 01/24/2021 | 24,552 |
| COWAN GREGORY L | Director | 05/21/2020 | 51,115 |
| WEISS FRED G | Director | 05/21/2020 | 81,779 |
| COWAN GREGORY L | Director | 01/28/2020 | 38,535 |
| Schaub James | EVP and COO | 01/28/2020 | 64,379 |
| Klein Christopher | General Counsel & Secretary | 01/28/2020 | 64,036 |
| Einhorn Andrew J. | Chief Financial Officer | 01/28/2020 | 64,288 |
| WEISS FRED G | Director | 01/28/2020 | 38,535 |
| deVries Tina Marie | EVP, Research & Development | 01/28/2020 | 63,980 |
| Harsaul Foundation | 10% Owner | 01/13/2020 | 6,250,000 |
| Altchem Ltd | 10% Owner | 01/13/2020 | 6,250,000 |
| Venkataraman Sriram | Director | 01/13/2020 | 6,250,000 |
| Burgstahler David F | Director | 01/13/2020 | 6,250,000 |
| Avista Capital Partners III GP, L.P. | 10% Owner | 01/13/2020 | 6,250,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR OSMOTICA PHARMACEUTICALS PLC
STOCK BUYBACKS FOR OSMOTICA PHARMACEUTICALS PLC
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0.05%
1Q
12/31/2022
0.11%
2Q
09/30/2022
7.13%
3Q
06/30/2022
18.89%
4Q
03/31/2022
19.02%
5Q
12/31/2021
47.53%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OSMOTICA PHARMACEUTICALS PLC
LOADING...